ID   404C2
AC   CVCL_DP92
SY   404C-2
DR   GEO; GSM1040274
DR   GEO; GSM1040344
DR   GEO; GSM1489194
DR   GEO; GSM1489223
DR   GEO; GSM1489252
DR   GEO; GSM1489427
DR   SKIP; SKIP000821
DR   Wikidata; Q54602865
RX   PubMed=21460823;
RX   PubMed=24259714;
RX   PubMed=27476965;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   HLA typing: A*02:01; B*27:05,50:01; C*01:02;04:01; DQA1*01:01,05:01; DQB1*03:01,05:01; DRB1*01:01,13:03 (PubMed=30853558).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
RX   PubMed=27476965; DOI=10.1016/j.stem.2016.06.019;
RA   Nishizawa, Masatoshi
RA   Chonabayashi, Kazuhisa
RA   Nomura, Masaki
RA   Tanaka, Azusa
RA   Nakamura, Masahiro
RA   Inagaki, Azusa
RA   Nishikawa, Misato
RA   Takei, Ikue
RA   Oishi, Akiko
RA   Tanabe, Koji
RA   Ohnuki, Mari
RA   Yokota, Hidaka
RA   Koyanagi-Aoi, Michiyo
RA   Okita, Keisuke
RA   Watanabe, Akira
RA   Takaori-Kondo, Akifumi
RA   Yamanaka, Shinya
RA   Yoshida, Yoshinori
RT   "Epigenetic variation between human induced pluripotent stem cell
RT   lines is an indicator of differentiation capacity.";
RL   Cell Stem Cell 19:341-354(2016).
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110; PMCID=PMC3870695;
RA   Koyanagi-Aoi, Michiyo
RA   Ohnuki, Mari
RA   Takahashi, Kazutoshi
RA   Okita, Keisuke
RA   Noma, Hisashi
RA   Sawamura, Yuka
RA   Teramoto, Ito
RA   Narita, Megumi
RA   Sato, Yoshiko
RA   Ichisaka, Tomoko
RA   Amano, Naoki
RA   Watanabe, Akira
RA   Morizane, Asuka
RA   Yamada, Yasuhiro
RA   Sato, Tosiya
RA   Takahashi, Jun
RA   Yamanaka, Shinya
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=21460823; DOI=10.1038/nmeth.1591;
RA   Okita, Keisuke
RA   Matsumura, Yasuko
RA   Sato, Yoshiko
RA   Okada, Atsumasa
RA   Morizane, Asuka
RA   Okamoto, Satoshi
RA   Hong, Hyen-Jong
RA   Nakagawa, Masato
RA   Tanabe, Koji
RA   Tezuka, Ken-ichi
RA   Shibata, Toshiyuki
RA   Kunisada, Takahiro
RA   Takahashi, Masayo
RA   Takahashi, Jun
RA   Saji, Hiroh
RA   Yamanaka, Shinya
RT   "A more efficient method to generate integration-free human iPS
RT   cells.";
RL   Nat. Methods 8:409-412(2011).
//
RX   PubMed=30853558; DOI=10.1016/j.stem.2019.02.005;
RA   Xu, Huai-Geng
RA   Wang, Bo
RA   Ono, Miyuki
RA   Kagita, Akihiro
RA   Fujii, Kaho
RA   Sasakawa, Noriko
RA   Ueda, Tatsuki
RA   Gee, Peter
RA   Nishikawa, Misato
RA   Nomura, Masaki
RA   Kitaoka, Fumiyo
RA   Takahashi, Tomoko
RA   Okita, Keisuke
RA   Yoshida, Yoshinori
RA   Kaneko, Shin
RA   Hotta, Akitsu
RT   "Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with
RT   enhanced immune compatibility.";
RL   Cell Stem Cell 24:566-578.e7(2019).
//